Michael S Perry - Net Worth and Insider Trading
Michael S Perry Net Worth
The estimated net worth of Michael S Perry is at least $5 Million dollars as of 2024-12-28. Michael S Perry is the Director of AVITA Medical Inc and owns about 229,543 shares of AVITA Medical Inc (RCEL) stock worth over $3 Million. Michael S Perry is the Director of Arrowhead Pharmaceuticals Inc and owns about 85,500 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $2 Million. Michael S Perry is also the Director of Armata Pharmaceuticals Inc and owns about 29,381 shares of Armata Pharmaceuticals Inc (ARMP) stock worth over $61,994. Details can be seen in Michael S Perry's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael S Perry has not made any transactions after 2022-11-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael S Perry
Michael S Perry Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael S Perry owns 5 companies in total, including AVITA Medical Inc (RCEL) , Arrowhead Pharmaceuticals Inc (ARWR) , and Armata Pharmaceuticals Inc (ARMP) among others .
Click here to see the complete history of Michael S Perry’s form 4 insider trades.
Insider Ownership Summary of Michael S Perry
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RCEL | AVITA Medical Inc | 2022-11-21 | director & Chief Executive Officer |
ARWR | Arrowhead Pharmaceuticals Inc | 2022-01-03 | director |
ARMP | Armata Pharmaceuticals Inc | 2019-12-31 | director |
2012-03-27 | President & CMO | ||
2007-05-03 | director |
Michael S Perry Latest Holdings Summary
Michael S Perry currently owns a total of 3 stocks. Among these stocks, Michael S Perry owns 229,543 shares of AVITA Medical Inc (RCEL) as of November 21, 2022, with a value of $3 Million and a weighting of 64.79%. Michael S Perry owns 85,500 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of January 3, 2022, with a value of $2 Million and a weighting of 33.92%. Michael S Perry also owns 29,381 shares of Armata Pharmaceuticals Inc (ARMP) as of March 22, 2018, with a value of $61,994 and a weighting of 1.3%.
Latest Holdings of Michael S Perry
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RCEL | AVITA Medical Inc | 2022-11-21 | 229,543 | 13.49 | 3,096,535 |
ARWR | Arrowhead Pharmaceuticals Inc | 2022-01-03 | 85,500 | 18.96 | 1,621,080 |
ARMP | Armata Pharmaceuticals Inc | 2018-03-22 | 29,381 | 2.11 | 61,994 |
Holding Weightings of Michael S Perry
Michael S Perry Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael S Perry has made a total of 5 transactions in AVITA Medical Inc (RCEL) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in AVITA Medical Inc is the sale of 150,000 shares on November 21, 2022, which brought Michael S Perry around $1 Million.
According to the SEC Form 4 filings, Michael S Perry has made a total of 3 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 4,500 shares on January 3, 2022, which brought Michael S Perry around $291,195.
According to the SEC Form 4 filings, Michael S Perry has made a total of 0 transactions in Armata Pharmaceuticals Inc (ARMP) over the past 5 years. The most-recent trade in Armata Pharmaceuticals Inc is the acquisition of 20,900 shares on March 22, 2018, which cost Michael S Perry around $198,963.
Insider Trading History of Michael S Perry
- 1
Michael S Perry Trading Performance
GuruFocus tracks the stock performance after each of Michael S Perry's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael S Perry is 5.17%. GuruFocus also compares Michael S Perry's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael S Perry within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael S Perry's insider trading performs compared to the benchmark.
Performance of Michael S Perry
Michael S Perry Ownership Network
Michael S Perry Owned Company Details
What does AVITA Medical Inc do?
Who are the key executives at AVITA Medical Inc?
Michael S Perry is the director & Chief Executive Officer of AVITA Medical Inc. Other key executives at AVITA Medical Inc include CFO David D O'toole , General Counsel Donna Shiroma , and Chief Financial Officer Michael Holder .
AVITA Medical Inc (RCEL) Insider Trades Summary
Over the past 18 months, Michael S Perry made no insider transaction in AVITA Medical Inc (RCEL). Other recent insider transactions involving AVITA Medical Inc (RCEL) include a net purchase of 17,675 shares made by David D O'toole , a net sale of 5,018 shares made by Jeremy Curnock Cook , and a net sale of 4,193 shares made by Donna Shiroma .
In summary, during the past 3 months, insiders sold 0 shares of AVITA Medical Inc (RCEL) in total and bought 975 shares, with a net purchase of 975 shares. During the past 18 months, 10,656 shares of AVITA Medical Inc (RCEL) were sold and 17,675 shares were bought by its insiders, resulting in a net purchase of 7,019 shares.
AVITA Medical Inc (RCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.
AVITA Medical Inc Insider Transactions
Michael S Perry Mailing Address
Above is the net worth, insider trading, and ownership report for Michael S Perry. You might contact Michael S Perry via mailing address: C/o Biotransplant Inc, 196 Boston Ave Suite 2800, Medford Ma 02155.